283 related articles for article (PubMed ID: 35294165)
1. Transforming Nuclear Medicine with Nanoradiopharmaceuticals.
Roy I; Krishnan S; Kabashin AV; Zavestovskaya IN; Prasad PN
ACS Nano; 2022 Apr; 16(4):5036-5061. PubMed ID: 35294165
[TBL] [Abstract][Full Text] [Related]
2. An overview of nanoscale radionuclides and radiolabeled nanomaterials commonly used for nuclear molecular imaging and therapeutic functions.
Farzin L; Sheibani S; Moassesi ME; Shamsipur M
J Biomed Mater Res A; 2019 Jan; 107(1):251-285. PubMed ID: 30358098
[TBL] [Abstract][Full Text] [Related]
3. Nuclear nanomedicine using Si nanoparticles as safe and effective carriers of
Petriev VM; Tischenko VK; Mikhailovskaya AA; Popov AA; Tselikov G; Zelepukin I; Deyev SM; Kaprin AD; Ivanov S; Timoshenko VY; Prasad PN; Zavestovskaya IN; Kabashin AV
Sci Rep; 2019 Feb; 9(1):2017. PubMed ID: 30765778
[TBL] [Abstract][Full Text] [Related]
4. Nanoradiopharmaceuticals: is that the future for nuclear medicine?
Santos-Oliveira R
Curr Radiopharm; 2011 Apr; 4(2):140-3. PubMed ID: 22191653
[TBL] [Abstract][Full Text] [Related]
5. All-in-One Nanomedicine: Multifunctional Single-Component Nanoparticles for Cancer Theranostics.
Cai Y; Chen X; Si J; Mou X; Dong X
Small; 2021 Dec; 17(52):e2103072. PubMed ID: 34561968
[TBL] [Abstract][Full Text] [Related]
6. PAMAM Dendrimer-Based Nanodevices for Nuclear Medicine Applications.
Xiao T; Li D; Shi X; Shen M
Macromol Biosci; 2020 Feb; 20(2):e1900282. PubMed ID: 31829523
[TBL] [Abstract][Full Text] [Related]
7. Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy.
Ting G; Chang CH; Wang HE; Lee TW
J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20811605
[TBL] [Abstract][Full Text] [Related]
8. Theranostic approaches in nuclear medicine: current status and future prospects.
Filippi L; Chiaravalloti A; Schillaci O; Cianni R; Bagni O
Expert Rev Med Devices; 2020 Apr; 17(4):331-343. PubMed ID: 32157920
[No Abstract] [Full Text] [Related]
9. Nanoparticles for SPECT and PET Imaging: Towards Personalized Medicine and Theranostics.
Polyak A; Ross TL
Curr Med Chem; 2018; 25(34):4328-4353. PubMed ID: 28875837
[TBL] [Abstract][Full Text] [Related]
10. One stone, many birds: Recent advances in functional nanogels for cancer nanotheranostics.
Wang H; Picchio ML; Calderón M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1791. PubMed ID: 35338603
[TBL] [Abstract][Full Text] [Related]
11. Radiolabelled nanoparticles: novel classification of radiopharmaceuticals for molecular imaging of cancer.
Mirshojaei SF; Ahmadi A; Morales-Avila E; Ortiz-Reynoso M; Reyes-Perez H
J Drug Target; 2016; 24(2):91-101. PubMed ID: 26061297
[TBL] [Abstract][Full Text] [Related]
12. The bright future of radionuclides for cancer therapy.
Nijsen JF; Krijger GC; van Het Schip AD
Anticancer Agents Med Chem; 2007 May; 7(3):271-90. PubMed ID: 17504155
[TBL] [Abstract][Full Text] [Related]
13. Advancements in the development of radiopharmaceuticals for nuclear medicine applications in the treatment of bone metastases.
Dyer MR; Jing Z; Duncan K; Godbe J; Shokeen M
Nucl Med Biol; 2024; 130-131():108879. PubMed ID: 38340369
[TBL] [Abstract][Full Text] [Related]
14. Lanthanide-Activated Nanoparticles: A Toolbox for Bioimaging, Therapeutics, and Neuromodulation.
Yi Z; Luo Z; Qin X; Chen Q; Liu X
Acc Chem Res; 2020 Nov; 53(11):2692-2704. PubMed ID: 33103883
[TBL] [Abstract][Full Text] [Related]
15. Neutron-activated theranostic radionuclides for nuclear medicine.
Tan HY; Yeong CH; Wong YH; McKenzie M; Kasbollah A; Md Shah MN; Perkins AC
Nucl Med Biol; 2020; 90-91():55-68. PubMed ID: 33039974
[TBL] [Abstract][Full Text] [Related]
16. Radionuclide-Activated Nanomaterials and Their Biomedical Applications.
Ferreira CA; Ni D; Rosenkrans ZT; Cai W
Angew Chem Int Ed Engl; 2019 Sep; 58(38):13232-13252. PubMed ID: 30779286
[TBL] [Abstract][Full Text] [Related]
17. Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine.
Chen Z; Krishnamachary B; Pachecho-Torres J; Penet MF; Bhujwalla ZM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1595. PubMed ID: 31642207
[TBL] [Abstract][Full Text] [Related]
18. Theranostic Advances in Breast Cancer in Nuclear Medicine.
Vahidfar N; Aghanejad A; Ahmadzadehfar H; Farzanehfar S; Eppard E
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925632
[TBL] [Abstract][Full Text] [Related]
19. Exogenous/Endogenous-Triggered Mesoporous Silica Cancer Nanomedicine.
Yang B; Chen Y; Shi J
Adv Healthc Mater; 2018 Oct; 7(20):e1800268. PubMed ID: 29938917
[TBL] [Abstract][Full Text] [Related]
20. Coupling metal organic frameworks with molybdenum disulfide nanoflakes for targeted cancer theranostics.
Yang S; Li D; Chen L; Zhou X; Fu L; You Y; You Z; Kang L; Li M; He C
Biomater Sci; 2021 May; 9(9):3306-3318. PubMed ID: 33459315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
